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Shwasa is one among the major disease explained in 
Ayurveda and is caused due to vitiation of Kapha and 
Vata Dosha originating from Pittasthana.
[1]
 When the 
normal passage of Pranavayu is obstructed by Kapha, 
it gets vitiated and starts moving in opposite 
direction,  due  to  which it  is  unable  to  perform  its 
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normal physiological work and produce Shwasa 
Roga.
[2]
 Tamaka Shwasa is a type of Shwasa in which 
there is excessive difficulty in respiration and feeling 
of drowning in the dark. According to Acharya 
Charaka - Vata Dosha moves in the opposite 
direction, pervades the channels, afflicts head and 
neck, and stimulates the Kapha to cause rhinitis, 
wheezing, cough, faintness, disturbed sleep etc. The 
attack gets aggravated in cloudy season, on exposure 
to cold air and cold water and with the restoration of 
Kapha aggravating food and regimens. The other 
psychosomatic factors like anxiety, grief and fear also 
aggravate the Shwasa Roga. The disease Tamaka 




In the treatment of Tamaka Shwasa, avoidance of 
causative factors or triggering factors plays a very 
important role. “Elimination of the causative agent(s) 
from the environment of an allergic individual with 
A B S T R A C T  
Ayurveda is the science of life which deals with the prevention and cure of diseases. From the first 
breath of newly born till the last breath i.e, Shwasochhwasa Kriya is the sign of life. Any disturbance 
in this process leads to Shwasa Roga. Tamaka Shwasa is one of the important diseases of such 
disturbance. Shwasa is a Kapha-Vataja disease which is originated from Pittasthana. Tamaka Shwasa 
is very much similar to bronchial asthma in modern medicine which is a chronic disease of 
multifactorial origin. Ayurveda describes two type of management of all disease i.e. Shodhana and 
Shamana Chikitsa. In present scenario Panchakarma therapy is the best way to effectively and safely 
manage the condition without any specific side effects. It is one of the most effective and complete 
therapy in the management of the chronic disease such as Tamaka Shwasa (Bronchial Asthma). In 
Ayurvedic classics both Vamana and Virechana have been described specifically in the management of 
Tamaka Shwasa. Considering the Ayurvedic  concept of treatment of Tamaka Shwasa, in present 
study we have used Virechana therapy along with certain herbal preparation. In this study we 
concluded that the cases who were treated with herbal preparation along with Virechana got better 
relief than herbal preparation alone. 
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Beside avoidance of causative factors, Acharya 
Charaka advocates use of both Vamana and 
Virechana therapy. Acharya Charaka has specifically 
mentioned ‘Tamake Tu Virechane’ in the management 
of Tamaka Shwasa. Now the question arises that 
Tamaka Shwasa is said to be Vatakaphatamaka 
Vyadhi, then why Acharya suggest Virechana. The 
probable answer to the following questions lies in the 
following facts- 
 Shwasa is Pitta Sthana Samudbhava Vyadhi and 
thus according to the site of origin Virechana is 
most suitable treatment for every type of Shwasa.  
 In Tamaka Shwasa, Kapha obstruct the passage of 
Vata and the obstructed Vata traverse in reverse 
direction. For Vatanulomana, Virechana is more 
suitable than Vamana. 
 Basti is best therapy if only Vata is vitiated, but 
when Vata is associated with other Doshas, then 
Mridu Samshodhana or Mriduvirechana is best.
[6]
 
 In Tamaka Shwasa there is Samavayu. Mridu 
Virechana not only helps in eliminating Ama from 
the body, but simultaneously it also helps in Vata 
Anulomana. Thus if Vata is associated with Ama, 
Virechana is most appropriate. 
 In the context of Vatika Kasa, Acharya gives 
instruction for using Basti in case if only Vata is 




 In Tamaka Shwasa, there is obstruction of Vata by 
Kapha, thus there is Kaphavrita Vata and 
Virechana is mentioned in the treatment of 
Kaphavrita Vata. 
According to Acharya Charaka, ingredients which 
causes alleviation of Vata and Kapha, which are hot in 
potency, and which causes Vatanulomana are useful 
as medicines, drinks and food preparations for the 
patients suffering from Tamaka Shwasa.
[8] 
Literary simulation of Tamaka Shwasa coincides with 
the description of bronchial asthma as described in 
modern literature. It is very distressing disease of 
respiratory system producing dyspnoea and 
discomfort, making life miserable. In India around 15-
20 million new cases of asthma develops every year. 
The survey report states that the disease occurs at 
very young age and one in every six child under the 
age of 16 is affected.  Though Tamaka Shwasa is not 
merely bronchial asthma, umbrella of Tamaka Shwasa 
covers all the types of manageable dyspnoea including 
cardiac, renal and pulmonary asthma. It also includes 
other pulmonary causes of dyspnoea such as COPD. In 
the present study it is desired to evaluate the effect of 
drug on bronchial asthma rather than on Tamaka 
Shwasa. 
 
MATERIALS AND METHODS 
This study was carried on 60 patients of Tamaka 
Shwasa, the patient who fulfilled the clinical 
diagnostic criteria of Tamaka Shwasa (Bronchial 
Asthma) were randomly selected, irrespective of their 
sex, religion, occupation etc. from the OPD and IPD 
wing of Department of Kayachikitsa, S.S. Hospital, 
IMS, BHU, Varanasi. 
Selection of Sample  
Randomized Sampling {Unrestricted Randomized 
Stratified Method} 
Nature of Study: Control Study 
Trial Methodology: Open Trial 
For this study, patients were divided into four groups: 
1. Group A: 15 registered patient of Tamaka Shwasa 
were administered Shatyadi Churna for two 
months with 15 days follow up.  
2. Group B: 15 registered patients of Tamaka 
Shwasa were given Shatyadi Churna and Bharangi 
Shunthi Kwatha as Anupana for two months with 
15 days follow up. 
3. Group C: 15 registered patients of Tamaka 
Shwasa were given above Shodhana Pooravaka 
Samana Chikitsa for two month, with 15 days 
follow up. 
4. Group D: 15 registered patients of Bronchial 
Asthma were given modern medication, as 
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control group for two months with 15 days follow 
up. 
Exclusion Criteria  
Patients having following criteria; 
 Bronchial Carcinoma 
 Chronic Obstructive Pulmonary Disease 
 Pleural Effusion 
 Tuberculosis 
 Status Asthmaticus 
 Cardiac Asthma 
Patients who were not able to tolerate Shodhana 
therapy were not taken in Shodhana group. 
Inclusion Criteria 
 Newly onset uncomplicated Bronchial Asthma. 
 Mild and Moderate Bronchial Asthma. 
Criteria for Drug Selection   
Drug selected for present study are Shatyadi Churna 
and Bharangi Shunthi Kwatha. Drugs were selected on 
the guidelines given by Acharya and Research works 
conducted regarding these drugs in various research 
institutes. Contents of Shatyadi Churna are Shati, 
Tamalaki, Pushkarmoola, Shunthi, Pippali, Ela, Tulsi, 
Musta, Twak, Balaka, Bharangi, Agru in equal parts 
and Sharkara twelve parts.
[9]
 Bharangi Shunthi 









Drugs Dose Duration 
A 15 Shatyadi 
Churna 
3 gms thrice 




B 15 Shatyadi 
Churna 






30 ml as 
Anupana 
C 15 Chitrakadi 
Vati 
2 tab thice 
in a day 
3 days 
Go Ghrita 30ml to 
210ml 









 1 day 
Sansarjana 
Karma 









D 15 Tab. 
Doxophyllin 
400mg  OD 2 months 
Assessment criteria  
The improvement provided by the therapy was 
assessed by clinical sign and symptoms of bronchial 
asthma. For this purpose a special research proforma 
was prepared to assess the detailed history of the 
patients. The scoring and gradation pattern for the 
assessment is shown below- 
Table 2: Symptom grading scale 
Grade  Percentage  Number  Sign of grade  
Nil  0% 0 - 
Mild  25% 1 + 
Moderate  50% 2 ++ 
Severe  75% 3 +++ 
Agonizing  100% 4 ++++ 
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The details of the assessment of symptoms rating is 
given below: 
1. Dyspnoea (Breathlessness) 
Not troubled by shortness of breath on 
level or uphill. 
None  0 
Troubled by shortness of breath on level 
or uphill 
Mild  1 
Walks slower than person of same age 
(Breathlessness at the time of simple 
walking) 
Moderate  2 
Stops after walking 100 yards Severe  3 
Breathlessness at rest Agonizing  4 
2. Cough  
No cough  None  0 
Coughing for 2-5 min, frequency 1-2 
times/day, without pain, wet with easy 
expectoration. 
Mild  1 
Coughing for more than 10 min, 
frequency more than 5-10 times/day, 
with pain, expectoration with slight 
difficulties, disturbed sleep 
Moderate  2 
Coughing for more than 15 min, 
frequency 5-10 times/day, with pain, 
feeling of restlessness due to difficulty 
in expectoration, marked disturbance 
in sleep 
Severe  3 
Frequent coughing due to which 
patient becomes  unconscious 
Agonizing  4 
3. Wheezing  
No wheezing None  0 
Intermittent wheezing present only 
during attack  
Mild  1 
Wheezing only at early morning or 
during physical exertion  
Moderate  2 
Constant wheezing throughout day Severe  3 
Constant wheezing along with added 
respiratory sound 
Agonizing  4 
4. Chest tightness 
No chest tightness None 0 
Only during attack Mild 1 
Very often even without attack, relieves 
without medication 
moderate 2 
Persistent chest tightness severe 3 
Laboratory Investigation 
a. Haematological investigations after completion of 
treatment were repeated 
b. Respiratory function tests were repeated during 
the treatment. 
 FVC (Forced vital capacity). 
 FEV1 (Forced expiratory volume in one 
second). 
 PEFR (Peak Expiratory Flow Rate). 
Follow- up study 
After the completion of the treatment, the follow up 
study was done every 2 weekly for two months to 
note the recovery of attacks and symptoms. 
STATISTICAL ANALYSIS 
Students paired ‘t’ test, Wilcoxon signed ranks test 
and Friedman test were applied for the calculations. 
OBSERVATIONS AND RESULTS 
Out of the 60 patients registered for the study, 7 
patients dropped out and the remaining 53 patients 
completed the full course of treatment. Among the 
total registered patients 51.7% are in the age group of 
16-35 years, 53.3% were male, 95% were hindu, 
68.3%% belonged to lower middle class, 48.3% were 
graduate, 31.7% were student, 81.7% were from rural 
habitat, 35% of patients presented with more than 1 
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Among the four Groups, comparison (BT
T-test shows greater increase in Group
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DISCUSSION 
Bronchial asthma is more prevalent in 
age Groups. W.H.O. stated that prevalen
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allergic, anti-spasmodic and bronchodilator effect of 
contents present in the drug. 
CONCLUSION  
On the basis of observations made, results obtained 
and our discussion on what can be the probable mode 
of action of drugs and Virechana therapy, it is 
concluded that Shatyadi Churna has bronchodilator 
and anti-tussive properties but its anti-eosinophilic 
effect is less prominent. Bharangi Shunthi Kwatha also 
has bronchodilator activity. It potentiated the effect 
when given as Anupana of Shatyadi Churna. 
Virechana Karma doesn’t have any direct 
bronchodilator effect, but it relieves the symptoms by 
alleviating the associated conditions which provoke 
asthma attacks such as GERD, constipation, flatulance 
etc.  
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